Bionote, Inc. manufactures and distributes animal diseases diagnostic kits and equipment. The Company provides immunochemical diagnosis, point of care, enzyme immunoassay, fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, enzyme linked immunosorbent assay, and other related services. Bionote markets its products worldwide.

(Forewarning) Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading)

Organization of Investor Relations Event

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bionote (377740 KS)

(Forewarning) Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading)

Organization of Investor Relations Event

Outcome of Annual Shareholders' Meeting

Submission of Audit Report

[Revised] Decision on Calling Shareholders' Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)